Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification
While seizures are not an expected complication of GLP-1 receptor agonist therapy, any seizure-like event requires urgent assessment regardless of medication use
Preclinical literature reports the use of thymosin beta-4-related peptides in neural, vascular, cutaneous, and cardiovascular models, with histological, biochemical, and molecular analyses aimed at evaluating stress markers, cytoskeletal organization, and tissue response
So, something like quercetin would be better there, for anyone that has issues with citrus, and quercetin as well is also amazing at stabilizing those mast cells
Recently, rare but serious psychiatric adverse events (AEs) associated with GLP1-RA, such as suicide and self-injury, have gained attention [Reference ONeil, Aroda, Astrup, Kushner, Lau and Wadden7]